The relaxant 5‐HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5‐ht7 receptor subtype
Open Access
- 19 July 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 118 (6) , 1421-1428
- https://doi.org/10.1111/j.1476-5381.1996.tb15555.x
Abstract
1 The relaxant effect of 5-hydroxytryptamine (5-HT) in the dog isolated coronary artery deprived of endothelium is mediated by a receptor unrelated to the 5-HT1, 5-HT2, 5-HT3 or 5-HT4 types. Based upon the pharmacological characteristics of this relaxant 5-HT receptor and those reported for the new members of the 5-HT receptor family, the present study explored the possibility that the relaxant 5-HT receptor referred to above, corresponds to the cloned 5-ht7 subtype. Thus, the relaxing and/or blocking effects of several 5-HT receptor drugs as well as some typical and atypical antipsychotic drugs with high affinity for the cloned 5-ht7 receptor in precontracted ring segments were analyzed. 2 5-HT, 5-carboxamidotryptamine (5-CT) and 5-methoxytryptamine, but not 8-OH-DPAT or sumatriptan, produced concentration-dependent relaxations in endothelium-denuded canine coronary artery rings precontracted with prostaglandin F2α (2 μm). Clozapine (1 μm) produced in some cases a small relaxing effect and antagonized 5-HT- and 5-CT-induced relaxation suggesting a partial agonist effect. In the presence of the 5-HT1D receptor antagonist, GR127935 (100 nM), the rank order of agonist potency was 5-CT > 5-HT > clozapine ≥ 5-methoxytryptamine. 8-OH-DPAT and sumatriptan remained inactive as agonists. 3 In GR 127935-treated preparations, methiothepin (3 nM) and mianserin (1 μm), as well as the antipsychotics, clozapine (1 μm), pimozide (300 nM), risperidone (3 nM) and spiperone (1 μm), failed to induce a significant relaxation in prostaglandin F2α-precontracted vessels, but produced significant rightward displacements of the concentration-response curves to 5-HT and 5-CT without significantly reducing the Emax. In a final set of experiments with 5-CT, metergoline (100 nM) and mesulergine (300 nM) behaved as competitive antagonists. In contrast, lisuride (3 nM) noncompetitively antagonized 5-CT-induced relaxation. The estimated affinity (apparent pKB values) of the above antagonist drugs for the relaxant 5-HT receptor significantly correlated with their reported affinity at the cloned 5-ht7 receptor. 4 Taken together, the above pharmacological data may suggest that the relaxant 5-HT receptor in the smooth muscle of the canine coronary artery is similar to the cloned 5-ht7 receptor subtype.Keywords
This publication has 14 references indexed in Scilit:
- GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary arteryEuropean Journal of Pharmacology, 1996
- Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brainBritish Journal of Pharmacology, 1995
- Serotonin-induced contraction in canine coronary artery and saphenous vein: Role of a 5-HT1D-like receptorLife Sciences, 1994
- Vascular receptors for 5-hydroxytryptamine: Distribution, function and classificationPharmacology & Therapeutics, 1994
- A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsNeuron, 1993
- Developmental regulation of 5-HT2 and 5-HT1C mRNA and receptor levelsDevelopmental Brain Research, 1991
- 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexusNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of actionLife Sciences, 1986
- Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries.Circulation Research, 1983
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979